Combating Chronic Renal Allograft Dysfunction: Optimal Immunosuppressive Regimens

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.5, 2005-01, pp. : 615-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients: An Overview

By Höcker Britta Tönshoff Burkhard

Pediatric Drugs, Vol. 11, Iss. 6, 2009-12 ,pp. : 381-396

Adis International

Access to resources Recommend Favorite

Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective

By Walters S.J. Whitfield M. Akehurst R.L. Chilcott J.B.

PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction

By Dogterom P.

Clinical Drug Investigation, Vol. 22, Iss. 8, 2002-08 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Cardiac allograft endothelial dysfunction

By Kofler Sieglinde Petrakopoulou Paraskevi Nickel Thomas Weis Michael

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 79-82

Springer Publishing Company

Access to resources Recommend Favorite

Immunosuppressive Preconditioning or Induction Regimens: Evidence to Date

By Tan Henkie P.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1535-1545

Adis International

Access to resources Recommend Favorite